AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 281: F693-F706, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lieberthal, W.
Right arrow Articles by Levine, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lieberthal, W.
Right arrow Articles by Levine, J. S.
Vol. 281, Issue 4, F693-F706, October 2001

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

Wilfred Lieberthal1, Robert Fuhro1, C. Christopher Andry2, Helmut Rennke3, Vivian E. Abernathy1, Jason S. Koh1, Robert Valeri4, and Jerrold S. Levine5

1 Renal Section, Evans Memorial Department of Clinical Research, Department of Medicine, 4 Naval Blood Research Laboratory, and 2 Department of Pathology, Boston University Medical Center, Boston 02118; 3 Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115; and 5 Section of Nephrology, Biological Sciences Division, University of Chicago, Chicago, Illinois 60637

The immunosuppressive effect of rapamycin is mediated by inhibition of interleukin-2-stimulated T cell proliferation. We report for the first time that rapamycin also inhibits growth factor-induced proliferation of cultured mouse proximal tubular (MPT; IC50 ~1 ng/ml) cells and promotes apoptosis of these cells by impairing the survival effects of the same growth factors. On the basis of these in vitro data, we tested the hypothesis that rapamycin would impair recovery of renal function after ischemic acute renal failure induced in vivo by renal artery occlusion (RAO). Rats given daily injections of rapamycin or vehicle were subjected to RAO or sham surgery. Rapamycin had no effect on the glomerular filtration rate (GFR) of sham-operated animals. In rats subjected to RAO, GFR fell to comparable levels 1 day later in vehicle- and rapamycin-treated rats (0.25 ± 0.08 and 0.12 ± 0.05 ml · min-1 · 300 g-1, respectively) (P = not significant). In vehicle-treated rats subjected to RAO, GFR increased to 0.61 ± 0.08 ml · min-1 · 300 g-1 on day 3 (P < 0.02 vs. day 1) and then rose further to 0.99 ± 0.09 ml · min-1 · 300 g-1 on day 4 (P < 0.02 vs. day 3). By contrast, GFR did not improve in rapamycin-treated rats subjected to RAO over the same time period. Rapamycin also increased apoptosis of tubular cells while markedly reducing their proliferative response after RAO. Furthermore, rapamycin inhibited activation of 70-kDa S6 protein kinase (p70S6k) in cultured MPT cells as well as in the renal tissue of rats subjected to RAO. We conclude that rapamycin severely impairs the recovery of renal function after ischemia-reperfusion injury. This effect appears to be due to the combined effects of increased tubular cell loss (via apoptosis) and profound inhibition of the regenerative response of tubular cells. These effects are likely mediated by inhibition of p70S6k.

ischemia; proliferation; 70-kDa S6 protein kinase


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Weimbs
Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1423 - F1432.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
E. Letavernier, P. Bruneval, C. Mandet, J.-P. D. Van Huyen, M.-N. Peraldi, I. Helal, L.-H. Noel, and C. Legendre
High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. R. Lock, S. H. Sacks, and M. G. Robson
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F76 - F81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Xie and Q. Guo
Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F107 - F115.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Keller, C. Daniel, H. Schocklmann, K.-H. Endlich, D. Kerjaschki, R. J. Johnson, and C. Hugo
Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2724 - 2735.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. R. Wahl, A. L. Serra, M. Le Hir, K. D. Molle, M. N. Hall, and R. P. Wuthrich
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 598 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. G.B. Bonegio, R. Fuhro, Z. Wang, C. R. Valeri, C. Andry, D. J. Salant, and W. Lieberthal
Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous Nephropathy
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2063 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H.-P. Marti and F. J. Frey
Nephrotoxicity of rapamycin: an emerging problem in clinical medicine
Nephrol. Dial. Transplant., January 1, 2005; 20(1): 13 - 15.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Tao, J. Kim, R. W. Schrier, and C. L. Edelstein
Rapamycin Markedly Slows Disease Progression in a Rat Model of Polycystic Kidney Disease
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 46 - 51.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al.
Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. C. Fervenza, P. M. Fitzpatrick, J. Mertz, S. B. Erickson, S. Liggett, S. Popham, D. N. Wochos, A. Synhavsky, S. Hippler, T. S. Larson, et al.
Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1288 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wu, C. E. N. Reiter, D. A. Antonetti, S. R. Kimball, L. S. Jefferson, and T. W. Gardner
Insulin Promotes Rat Retinal Neuronal Cell Survival in a p70S6K-dependent Manner
J. Biol. Chem., March 5, 2004; 279(10): 9167 - 9175.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. D. Smith, L. E. Wrenshall, R. F. Nicosia, R. Pichler, C. L. Marsh, C. E. Alpers, N. Polissar, and C. L. Davis
Delayed Graft Function and Cast Nephropathy Associated with Tacrolimus Plus Rapamycin Use
J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1037 - 1045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online